These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum Hepcidin Concentration in Individuals with Sickle Cell Anemia: Basis for the Dietary Recommendation of Iron. Omena J; Cople-Rodrigues CDS; Cardoso JDDA; Soares AR; Fleury MK; Brito FDSB; Koury JC; Citelli M Nutrients; 2018 Apr; 10(4):. PubMed ID: 29673144 [TBL] [Abstract][Full Text] [Related]
4. Decreased Hepcidin Levels Are Associated with Low Steady-state Hemoglobin in Children With Sickle Cell Disease in Tanzania. Lee N; Makani J; Tluway F; Makubi A; Armitage AE; Pasricha SR; Drakesmith H; Prentice AM; Cox SE EBioMedicine; 2018 Aug; 34():158-164. PubMed ID: 30056060 [TBL] [Abstract][Full Text] [Related]
5. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease. Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540 [TBL] [Abstract][Full Text] [Related]
6. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study. Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328 [TBL] [Abstract][Full Text] [Related]
7. Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease. Mangaonkar AA; Thawer F; Son J; Ajebo G; Xu H; Barrett NJ; Wells LG; Bowman L; Clair B; Patel N; Bora P; Jung G; Nemeth E; Kutlar A Br J Haematol; 2020 Jun; 189(6):1204-1209. PubMed ID: 32030737 [TBL] [Abstract][Full Text] [Related]
8. Hepcidin and Anemia in Surgical Critical Care: A Prospective Cohort Study. Cherry-Bukowiec JR; Engoren M; Wiktor A; Raghavendran K; Napolitano LM Crit Care Med; 2018 Jun; 46(6):e567-e574. PubMed ID: 29517550 [TBL] [Abstract][Full Text] [Related]
9. Hepcidin as a potential biomarker for blood doping. Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046 [TBL] [Abstract][Full Text] [Related]
10. Inflammation, Hemolysis, and Erythropoiesis Lead to Competitive Regulation of Hepcidin and Possibly Systemic Iron Status in Sickle Cell Disease. Ginzburg YZ; Glassberg J EBioMedicine; 2018 Aug; 34():8-9. PubMed ID: 30076048 [No Abstract] [Full Text] [Related]
11. Oxidative stress and hepcidin expression in pediatric sickle cell anemia with iron overload. Elbostany EA; Elghoroury EA; Thabet EH; Rashad AA; Rasheed EA; El-Saeed GSM; Abdelhalim DA; Abdelfattah SN; Salama II; Salama N Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):238-244. PubMed ID: 34883086 [TBL] [Abstract][Full Text] [Related]
12. Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin. Nekhai S; Xu M; Foster A; Kasvosve I; Diaz S; Machado RF; Castro OL; Kato GJ; Taylor JG; Gordeuk VR Haematologica; 2013 Mar; 98(3):455-63. PubMed ID: 23065513 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia. Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821 [TBL] [Abstract][Full Text] [Related]
14. Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota. Shanmugam NK; Trebicka E; Fu LL; Shi HN; Cherayil BJ J Immunol; 2014 Aug; 193(3):1398-407. PubMed ID: 24973448 [TBL] [Abstract][Full Text] [Related]
15. Hepcidin. Ganz T Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588 [TBL] [Abstract][Full Text] [Related]
16. Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis. Rybinska I; Cairo G Vitam Horm; 2017; 105():143-160. PubMed ID: 28629515 [TBL] [Abstract][Full Text] [Related]
17. Dysregulated Erythropoietin, Hepcidin, and Bone Marrow Iron Metabolism Contribute to Interferon-Induced Anemia in Hepatitis C. van Rijnsoever M; Galhenage S; Mollison L; Gummer J; Trengove R; Olynyk JK J Interferon Cytokine Res; 2016 Nov; 36(11):630-634. PubMed ID: 27617496 [TBL] [Abstract][Full Text] [Related]
18. Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric sickle cell disease. Lulla RR; Thompson AA; Liem RI Pediatr Blood Cancer; 2010 Jul; 55(1):141-4. PubMed ID: 20486179 [TBL] [Abstract][Full Text] [Related]
19. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes. Gu S; Song X; Zhao Y; Guo J; Fei C; Xu F; Wu L; Zhang X; Zhao J; Chang C; Li X Hematology; 2013 Sep; 18(5):286-94. PubMed ID: 23540794 [TBL] [Abstract][Full Text] [Related]
20. Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease. Duits AJ; Rojer RA; van Endt T; MacGillavry MR; ten Cate H; Brandjes DP; Schnog JB Ann Hematol; 2003 Mar; 82(3):171-4. PubMed ID: 12634950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]